Company Filing History:
Years Active: 2000-2005
Title: The Innovations of Donald Diehl, II
Introduction
Donald Diehl, II is an accomplished inventor based in Stony Point, NY (US). He holds a total of three patents, showcasing his contributions to the field of pharmaceuticals. His work primarily focuses on controlled release formulations, which are crucial for improving drug delivery and efficacy.
Latest Patents
One of his notable inventions is the "Once-a-day controlled release sulfonylurea formulation." This invention is directed to a novel solid matrixed controlled release oral dosage form. The dosage form contains a therapeutically effective amount of a sulfonylurea or a salt or derivative thereof in the matrix. Furthermore, the use of an aqueous alkalizing medium affords substantially complete bioavailability of the drug from the matrix of the tablet. The core tablets may optionally be coated with a coating material in the range of 2% to 10% with an enteric material or with a water-insoluble material like ethyl cellulose.
Career Highlights
Throughout his career, Donald Diehl, II has worked with several prominent companies, including Penwest Pharmaceuticals Company and Edward Mendell Co., Inc. His experience in these organizations has contributed significantly to his expertise in pharmaceutical formulations and innovations.
Collaborations
Some of his notable coworkers include Dileep Bhagwat and Anand R Baichwal. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.
Conclusion
Donald Diehl, II's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his significant role as an inventor. His work continues to impact drug delivery systems, enhancing patient care and treatment outcomes.